Header Logo
Keywords
Last Name
Institution
Announcement

You can now add alternative names! Click here to add other names that you've published under.

Adam Wolfe

Concepts (161)

Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Pancreatic Neoplasms
5
2024
234
2.780
Why?
Carcinoma, Pancreatic Ductal
3
2024
35
1.880
Why?
Radiation Tolerance
4
2019
87
1.320
Why?
Inflammatory Breast Neoplasms
3
2017
4
1.250
Why?
Neoplastic Stem Cells
3
2016
104
1.100
Why?
Lipoproteins, HDL
2
2016
21
1.080
Why?
Antineoplastic Combined Chemotherapy Protocols
3
2020
1060
1.070
Why?
Tumor Burden
3
2020
141
1.060
Why?
Proto-Oncogene Proteins B-raf
2
2021
92
0.950
Why?
Xenograft Model Antitumor Assays
4
2020
219
0.930
Why?
Cell Line, Tumor
10
2024
1551
0.820
Why?
Neoadjuvant Therapy
2
2020
125
0.730
Why?
Neutrophils
1
2021
154
0.720
Why?
Fellowships and Scholarships
1
2020
117
0.710
Why?
Physicians
1
2022
245
0.680
Why?
Cell Movement
2
2016
271
0.660
Why?
Forkhead Transcription Factors
2
2015
118
0.640
Why?
Melanoma
1
2021
313
0.630
Why?
Hydroxymethylglutaryl-CoA Reductase Inhibitors
2
2016
150
0.610
Why?
Macrophages
2
2017
404
0.600
Why?
Paracrine Communication
1
2016
12
0.590
Why?
Breast Neoplasms
2
2016
1249
0.570
Why?
Simvastatin
1
2015
35
0.540
Why?
Lipoproteins, VLDL
1
2015
16
0.530
Why?
Interleukin-6
1
2016
315
0.520
Why?
MicroRNAs
2
2016
386
0.510
Why?
Internship and Residency
1
2020
501
0.510
Why?
Mutation
1
2021
1504
0.500
Why?
Mice, SCID
3
2020
196
0.460
Why?
Inflammation
1
2016
678
0.420
Why?
Neoplasm Recurrence, Local
3
2021
645
0.400
Why?
Humans
21
2024
54391
0.400
Why?
Deoxycytidine
2
2020
28
0.380
Why?
Albumins
2
2020
39
0.380
Why?
Chemotherapy, Adjuvant
2
2020
119
0.370
Why?
Antineoplastic Agents
2
2016
1300
0.370
Why?
Paclitaxel
2
2020
103
0.360
Why?
Proportional Hazards Models
2
2021
430
0.350
Why?
Mice
6
2024
6428
0.310
Why?
Female
13
2022
28471
0.300
Why?
Signal Transduction
3
2024
1752
0.300
Why?
Aged, 80 and over
4
2021
3431
0.280
Why?
Animals
7
2024
14409
0.270
Why?
Cell Proliferation
3
2020
1097
0.260
Why?
Middle Aged
6
2021
13082
0.250
Why?
Retrospective Studies
3
2022
6459
0.250
Why?
Mice, Nude
3
2020
284
0.250
Why?
Caveolae
1
2024
7
0.250
Why?
Gene Expression Regulation, Neoplastic
2
2020
868
0.240
Why?
Endocytosis
1
2024
60
0.240
Why?
Hospitals, Community
1
2022
21
0.220
Why?
Career Mobility
1
2022
26
0.220
Why?
Arm
1
2022
52
0.220
Why?
Mentors
1
2022
55
0.210
Why?
Edema
1
2022
74
0.210
Why?
Neoplasm Staging
2
2021
805
0.200
Why?
Faculty, Medical
1
2022
100
0.200
Why?
Cell Cycle
2
2020
275
0.200
Why?
Caveolin 1
1
2020
22
0.190
Why?
Mice, Inbred NOD
1
2020
99
0.190
Why?
Lymphatic Metastasis
1
2021
256
0.190
Why?
Faculty
1
2020
84
0.190
Why?
Phosphorylation
3
2017
613
0.190
Why?
Leucovorin
1
2020
18
0.190
Why?
Radiotherapy, Adjuvant
1
2020
66
0.190
Why?
Fluorouracil
1
2020
61
0.180
Why?
Lymphocytes
1
2021
168
0.180
Why?
Radiation Dosage
1
2021
170
0.180
Why?
Spleen
1
2021
187
0.180
Why?
Coculture Techniques
2
2017
159
0.180
Why?
Drug Administration Schedule
1
2020
401
0.180
Why?
Male
7
2021
27347
0.180
Why?
Linear Models
1
2020
308
0.170
Why?
Survival Rate
3
2019
954
0.170
Why?
Radiation-Sensitizing Agents
1
2019
55
0.170
Why?
Carcinoma, Non-Small-Cell Lung
1
2021
164
0.170
Why?
DNA Breaks, Double-Stranded
1
2019
78
0.170
Why?
Child
2
2022
7368
0.170
Why?
Tumor Microenvironment
2
2017
210
0.170
Why?
Kaplan-Meier Estimate
1
2020
514
0.170
Why?
Aged
3
2021
10060
0.160
Why?
Interleukin-13
1
2017
16
0.160
Why?
STAT6 Transcription Factor
1
2017
10
0.160
Why?
Cell Polarity
1
2017
19
0.160
Why?
Interleukin-4
1
2017
48
0.160
Why?
DNA Repair
2
2019
203
0.160
Why?
Mice, Knockout
1
2020
927
0.160
Why?
Adult
4
2021
14207
0.150
Why?
Protein Kinase C
1
2017
65
0.150
Why?
Proto-Oncogene Proteins c-akt
2
2015
176
0.150
Why?
Macrophage Colony-Stimulating Factor
1
2016
10
0.150
Why?
Cell Survival
2
2019
657
0.150
Why?
Treatment Outcome
2
2020
5612
0.150
Why?
Thyroid Neoplasms
1
2019
162
0.150
Why?
STAT3 Transcription Factor
1
2016
88
0.140
Why?
Cell Dedifferentiation
1
2016
9
0.140
Why?
Adenocarcinoma
1
2020
428
0.140
Why?
Head and Neck Neoplasms
1
2019
336
0.140
Why?
Histone Deacetylase Inhibitors
1
2016
56
0.140
Why?
Neoplasm Invasiveness
1
2016
294
0.140
Why?
Tumor Stem Cell Assay
1
2015
21
0.130
Why?
Prognosis
1
2021
2126
0.130
Why?
Carcinoma, Ductal, Breast
1
2016
96
0.130
Why?
Anticholesteremic Agents
1
2015
34
0.130
Why?
Neoplasm Metastasis
1
2015
252
0.130
Why?
Dyslipidemias
1
2015
40
0.130
Why?
Lung Neoplasms
1
2021
643
0.130
Why?
Intercellular Signaling Peptides and Proteins
1
2015
122
0.120
Why?
Cholesterol
1
2015
155
0.120
Why?
Regression Analysis
1
2015
445
0.120
Why?
Receptor, IGF Type 1
1
2012
19
0.110
Why?
Receptor, Insulin
1
2012
44
0.110
Why?
src-Family Kinases
1
2012
54
0.110
Why?
Brain Neoplasms
1
2016
285
0.110
Why?
Bone Diseases
1
2012
108
0.100
Why?
Time Factors
1
2016
3210
0.090
Why?
Prostatic Neoplasms
1
2012
421
0.080
Why?
Apoptosis
1
2012
1302
0.070
Why?
Protein Kinase Inhibitors
2
2019
216
0.060
Why?
Neoplasm Grading
1
2020
131
0.050
Why?
Carboplatin
1
2019
63
0.040
Why?
Chemoradiotherapy
1
2019
42
0.040
Why?
Papillomaviridae
1
2019
107
0.040
Why?
Immunotherapy
1
2021
264
0.040
Why?
MAP Kinase Signaling System
1
2019
133
0.040
Why?
Diagnosis, Differential
1
2022
1141
0.040
Why?
Chemokine CCL22
1
2017
2
0.040
Why?
Phosphopeptides
1
2017
5
0.040
Why?
src Homology Domains
1
2017
9
0.040
Why?
Mannose-Binding Lectins
1
2017
10
0.040
Why?
Radiotherapy
1
2019
137
0.040
Why?
Biomimetic Materials
1
2017
11
0.040
Why?
Enzyme Induction
1
2017
80
0.040
Why?
Lectins, C-Type
1
2017
32
0.040
Why?
Fibronectins
1
2017
41
0.040
Why?
Papillomavirus Infections
1
2019
163
0.040
Why?
Molecular Mimicry
1
2017
64
0.040
Why?
Genetic Markers
1
2017
117
0.040
Why?
Cisplatin
1
2019
351
0.040
Why?
RNA, Small Interfering
1
2017
253
0.040
Why?
Receptors, Cell Surface
1
2017
130
0.040
Why?
Pentose Phosphate Pathway
1
2016
2
0.040
Why?
Glucosephosphate Dehydrogenase
1
2016
7
0.040
Why?
Randomized Controlled Trials as Topic
1
2019
594
0.040
Why?
Gene Knockdown Techniques
1
2016
125
0.030
Why?
Receptor, erbB-2
1
2016
79
0.030
Why?
Cadherins
1
2016
72
0.030
Why?
Disease-Free Survival
1
2016
488
0.030
Why?
Phenotype
1
2017
819
0.030
Why?
Infant
1
2022
3829
0.030
Why?
Immunoprecipitation
1
2012
73
0.030
Why?
Triazines
1
2012
30
0.030
Why?
Predictive Value of Tests
1
2016
1045
0.030
Why?
Thiazoles
1
2012
61
0.030
Why?
Enzyme-Linked Immunosorbent Assay
1
2012
314
0.030
Why?
Pyrazoles
1
2012
110
0.030
Why?
Tumor Cells, Cultured
1
2012
477
0.030
Why?
Drug Therapy, Combination
1
2012
426
0.030
Why?
Pyrimidines
1
2012
196
0.020
Why?
Blotting, Western
1
2012
684
0.020
Why?
Disease Models, Animal
1
2016
1647
0.020
Why?
Wolfe's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description